Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

URL of this page: https://medlineplus.gov/lab-tests/pten-genetic-test/

PTEN Genetic Test

What is a PTEN genetic test?

A PTEN genetic test uses a sample of your blood or other body tissue to look for changes in a gene called PTEN. Changes in your genes are also called gene variants or mutations.

Genes are parts of DNA in your cells that you inherit from your parents. You inherit two copies of each gene, one from each parent. Genes carry information that controls what you look like and how your body works.

PTEN is a type of gene called a "tumor suppressor." Tumor suppressor genes provide instructions for making proteins that help prevent or slow the growth of cells that may become tumors. The proteins work by:

  • Preventing cells from dividing too quickly to make new cells.
  • Repairing damaged DNA in cells.
  • Starting the normal process of cell death in cells that can't be repaired.

If you have certain changes in a PTEN gene, the gene or the protein it makes may not work well or may stop working completely. As a result, your cells may grow out of control, which can lead to tumors and cancer. Changes in your PTEN gene can be acquired or inherited.

Acquired changes in your genes are not passed down from your parents. They develop at some time after you're born. These kinds of changes are commonly found in many different types of cancer, including prostate cancer, uterine cancer, and some brain tumors.

Where you develop these gene changes, and how likely you are to develop them, depends on a variety of factors. These include:

  • Errors in DNA repair or when cells divide to make new cells. These errors can happen at any time. However, they become more common with age.
  • Being exposed to certain carcinogens (substances that increase your likelihood of getting cancer). For example, exposure to UV radiation from the sun and some artificial sources like tanning beds can lead to PTEN gene changes in your skin.
  • Having certain chronic viral infections. These viruses can damage your DNA and lead to PTEN gene changes that can cause cancer.

Inherited changes in your genes are changes that you're born with. They show up in all the cells in your body, including your egg or sperm cells. That means they can be passed from parent to child.

Inherited changes in the PTEN gene aren't common. But when they happen, they can cause several disorders that trigger the growth of benign tumors (not cancer). These tumors are called hamartomas. Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome are the two main disorders associated with inherited PTEN gene changes. They are often grouped together and called PTEN hamartoma tumor syndrome (PHTS).

Hamartomas and other symptoms of PHTS can show up in infancy or later. PHTS increases your risk for certain types of cancer, such as cancer of the breast, thyroid, and kidney. However, these changes usually don't develop until adulthood.

Other names: PTEN gene, full gene analysis; PTEN sequencing and deletion/duplication, PTEN FISH, chromosome 10 deletion, CHR 10

What is it used for?

The PTEN genetic test is used to look for changes in your PTEN gene. It's not a routine test. It may be used to:

  • Find out if a change in your PTEN gene is involved in cancer. If you do have a PTEN gene change, your health care provider may prioritize some treatments over others that wouldn't work on cancers without this gene change.
  • Check for inherited changes in your PTEN gene if you have symptoms of PHTS or family members who have PTEN gene changes.

Why do I need a PTEN genetic test?

If you have cancer, you may need a PTEN genetic test to check whether your cancer cells have a PTEN gene change. Genetic changes in cancer can affect how the disease responds to treatment and how it may behave over time. So, your test results can help guide your treatment plan.

If you have a family history of PTEN gene changes and/or symptoms of PHTS, a PTEN genetic test can help you understand and manage your cancer risk. The test can also show whether you have a genetic change that you could pass on to your children.

You or your child may need a test if you have symptoms of PHTS, which include:

If you're pregnant and have a family history of PTEN gene changes, you may consider having the test as part of your prenatal testing. The test can show whether your baby could be born with PHTS.

What happens during a PTEN genetic test?

If you're having a PTEN genetic test because you have cancer, the type of sample used will depend on your cancer:

  • For solid tumors, the test often uses a sample of tissue from the tumor. The tissue sample may be taken during surgery to remove the tumor. If you're not having surgery, you may have a biopsy of the tumor to remove a small amount of tissue. Health care professionals can do this by performing:
    • A fine needle aspiration biopsy. This procedure uses a very thin needle to remove a sample of cells from the tumor.
    • A core needle biopsy. This procedure uses a larger needle to remove a sample.
  • For blood or bone marrow cancer, a bone marrow test is often used. Marrow is soft, spongy tissue found inside of bones. Most bone marrow samples are taken from the back of the hip bone. You will be given an injection (shot) of medicine to numb the area. You may also be given medicine to help you relax or sleep. A bone marrow test has two parts that are usually done one after the other:
    • For a bone marrow aspiration, the provider pushes a hollow thin needle into the bone. A sample of bone marrow fluid is removed using a syringe attached to the needle.
    • For a bone marrow biopsy, the provider inserts a large hollow needle into the bone and twists the needle to take out a small piece of bone marrow tissue.

If you're having the test to look for inherited gene changes, you may have:

  • A blood test. During a blood test, a health care professional will use a small needle to remove a blood sample from a vein in your arm.
  • A buccal (cheek) swab. A health care professional will insert a swab into your mouth and rub it across the inside of your cheek to gather a sample of cells.

If you're testing a fetus, a sample may be gathered using:

  • Amniocentesis. This procedure collects a sample of the amniotic fluid that surrounds the fetus during pregnancy. The fluid contains cells from the fetus that can be tested. Amniocentesis is usually done between week 15 and 20 of pregnancy.
  • Chorionic villus sampling (CVS). This procedure collects tissue from the chorionic villi, which are parts of the placenta. The placenta is the organ that grows in the uterus to provide nutrients and oxygen to the fetus. The chorionic villi usually have the same genes as the fetus. A CVS is usually done between week 10 and 13 of pregnancy.

Will I need to do anything to prepare for the test?

If you're having a tissue biopsy or bone marrow test, ask your provider for instructions about how to prepare.

A blood test or cheek swab usually doesn't require any preparation.

For a CVS or amniocentesis, you may need to drink extra fluid and not urinate (pee) before your test so that your bladder is full.

Are there any risks to the test?

The risks of a biopsy depend on the type of biopsy you have. In general, you may have soreness, pain, or bleeding where the tissue was removed.

After a bone marrow test, you may feel stiff or sore where the sample was taken. This usually goes away in a few days. Serious risks are rare, but may include swelling, bleeding at the site, or fever.

A blood test has very little risk. You may have slight pain or bruising at the spot where the needle was put in, but most symptoms go away quickly.

A cheek swab has no risks.

During amniocentesis or CVS, you may feel mild stinging or cramping. Both procedures are safe, but they do have a slight risk of causing miscarriage. Talk with your provider about the risks and benefits of these tests.

What do the results mean?

If you have cancer and your test results show you have an acquired change in your PTEN gene, your provider can explain what it means for your treatment plan and future health.

If your test results show that you have certain inherited changes in your PTEN gene, it means you have PHTS. It doesn't mean you have cancer. However, your risk of cancer may be higher than most people. Your provider may discuss steps you can take to reduce your cancer risk, including:

For children, your provider may recommend a yearly exam that includes a skin check. Yearly thyroid ultrasound tests may begin at age seven. Your child may also need a checkup to see how their brain and nervous system are developing.

Learn more about laboratory tests, reference ranges, and understanding results.

Is there anything else I need to know about a PTEN genetic test?

If you're thinking about getting tested for an inherited change in your PTEN gene, it may help to talk with a genetic counselor. Genetic counselors are specially trained to help you understand the risks and benefits of testing for you and your family. This can help you make informed decisions.

If you've been diagnosed with an inherited change in your PTEN gene, a counselor can explain your risk for cancer. The counselor can also help you decide about testing your children and how to manage your risk over time.

References

  1. American Cancer Society [Internet]. Atlanta: American Cancer Society Inc.; c2025. Cowden Syndrome; [updated 2024 Mar 1; cited 2025 Sep 25]; [about 8 screens]. Available from: https://www.cancer.org/cancer/risk-prevention/genetics/family-cancer-syndromes/cowden-syndrome.html
  2. American Cancer Society [Internet]. Atlanta: American Cancer Society Inc.; c2025. Understanding Genetic Testing for Cancer Risk; [updated 2024 Jul 3; cited 2025 Sep 25]; [about 8 screens]. Available from: https://www.cancer.org/cancer/risk-prevention/genetics/genetic-testing-for-cancer-risk/understanding-genetic-testing-for-cancer.html
  3. American Cancer Society [Internet]. Atlanta: American Cancer Society Inc.; c2025. Hereditary Breast and Ovarian Cancer Syndrome (HBOC); [updated 2024 May 13; cited 2025 Sep 25]; [about 5 screens]. Available from: https://www.cancer.org/cancer/risk-prevention/genetics/family-cancer-syndromes/hboc-hereditary-breast-and-ovarian-cancer-syndrome.html
  4. American Cancer Society [Internet]. Atlanta: American Cancer Society Inc.; c2025. Targeted Therapy; [updated 2025 Jun 2; cited 2025 Sep 25]; [about 9 screens]. Available from: https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/targeted-therapy/what-is.html
  5. American Cancer Society [Internet]. Atlanta: American Cancer Society Inc.; c2025. Oncogenes, Tumor Suppressor Genes, and DNA Repair Genes; [updated 2022 Aug 31; cited 2025 Sep 25]; [about 5 screens]. Available from: https://www.cancer.org/healthy/cancer-causes/genetics/genes-and-cancer/oncogenes-tumor-suppressor-genes.html
  6. American Cancer Society [Internet]. Atlanta: American Cancer Society Inc.; c2025. Thyroid Cancer Risk Factors; [updated 2024 Aug 23; cited 2025 Sep 25]; [about 7 screens]. Available from: https://www.cancer.org/cancer/thyroid-cancer/causes-risks-prevention/risk-factors.html
  7. Centers for Disease Control and Prevention [Internet]. Atlanta: U.S. Department of Health and Human Services; Cancer Prevention and Control: Cancer Screening Tests; [updated 2025 Jan 16; cited 2025 Sep 25]; [about 2 screens]. Available from: https://www.cdc.gov/cancer/prevention/screening.html
  8. Children's Hospital of Philadelphia [Internet]. Philadelphia: The Children's Hospital of Philadelphia; c2025. What is PTEN Hamartoma Tumor Syndrome?; [cited 2025 Sep 25]; [about 13 screens]. Available from: https://www.chop.edu/conditions-diseases/pten-hamartoma-tumor-syndrome
  9. Cleveland Clinic: Health Library: Diagnostics & Testing [Internet]. Cleveland (OH): Cleveland Clinic; c2025. PTEN Hamartoma Tumor Syndrome; [reviewed 2022 Dec 16; cited 2025 Sep 25]; [about 13 screens]. Available from: https://my.clevelandclinic.org/health/diseases/17397-pten-hamartoma-tumor-syndrome-cowden-syndrome-and-bannayan-riley-ruvalcaba-syndrome
  10. Dillon LM, Miller TW. Therapeutic targeting of cancers with loss of PTEN function. Curr Drug Targets. 2014 Jan 9 [cited 2025 Sep 25];15(1):65-79. doi: 10.2174/1389450114666140106100909. PMID: 24387334; PMCID: PMC4310752. . Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4310752/
  11. Matreyek, K.A., Stephany, J.J., Ahler, E. et al. Integrating thousands of PTEN variant activity and abundance measurements reveals variant subgroups and new dominant negatives in cancers. Genome Med. [updated 2021 Oct 14; cited 2025 Sep 25] 13, 165 (2021). Available from: https://doi.org/10.1186/s13073-021-00984-x
  12. Mayo Clinic: Mayo Medical Laboratories [Internet]. Mayo Foundation for Medical Education and Research; c1995-2025. Test ID: PTNZ: PTEN Hamartoma Tumor Syndrome, PTEN Full Gene Analysis, Varies: Clinical and Interpretive; [cited 2025 Sep 25]; [about 3 screens]. Available from: https://www.mayocliniclabs.com/test-catalog/overview/614586#Clinical-and-Interpretive
  13. MD Anderson Cancer Center [Internet]. The University of Texas MD Anderson Cancer Center; c2025. Hereditary Cancer Syndromes; [cited 2025 Sep 25]; [about 4 screens]. Available from: https://www.mdanderson.org/prevention-screening/family-history/hereditary-cancer-syndromes.html
  14. National Cancer Institute [Internet]. Bethesda (MD): U.S. Department of Health and Human Services; Biomarker Testing for Cancer Treatment; [updated 2021 Dec 14; cited 2025 Sep 25]; [about 7 screens]. Available from: https://www.cancer.gov/about-cancer/treatment/types/biomarker-testing-cancer-treatment
  15. National Cancer Institute [Internet]. Bethesda (MD): U.S. Department of Health and Human Services; Genetic Testing for Hereditary Cancer Syndromes; [updated 2024 Apr 18; cited 2025 Sep 25]; [about 11 screens]. Available from: https://www.cancer.gov/about-cancer/causes-prevention/genetics/genetic-testing-fact-sheet
  16. National Cancer Institute [Internet]. Bethesda (MD): U.S. Department of Health and Human Services; NCI Dictionary of Cancer Terms: gene; [cited 2025 Sep 25]; [about 2 screens]. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gene
  17. National Organization for Rare Disorders [Internet]. Danbury (CT): National Organization for Rare Disorders; c2025. PTEN Hamartoma Tumor Syndrome; [updated 2023 Nov 7; cited 2025 Sep 25]; [about 18 screens]. Available from: https://rarediseases.org/rare-diseases/pten-hamartoma-tumor-syndrome
  18. Ngeow J, Eng C. PTEN in Hereditary and Sporadic Cancer. Cold Spring Harb Perspect Med. 2020 Apr 1;10(4):a036087. doi: 10.1101/cshperspect.a036087. PMID: 31570378; PMCID: PMC7117954. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7117954/
  19. Quest Diagnostics [Internet]. Quest Diagnostics; c2000-2025. Test Center: PTEN Sequencing and Deletion/Duplication; [cited 2025 Sep 25]; [about 3 screens]. Available from: https://testdirectory.questdiagnostics.com/test/test-detail/92566/pten-sequencing-and-deletionduplication?p=r&q=PTEN%20Sequencing%20and%20Deletion%2FDuplication&cc=MASTER
  20. St. Jude Children's Research Hospital [Internet]. Memphis (TN): St. Jude Children's Research Hospital; c2025. PTEN Hamartoma Tumor Syndrome; [updated 2020 May; cited 2025 Sep 25]; [about 12 screens]. Available from: https://www.stjude.org/disease/pten-hamartoma-tumor-syndrome.html
  21. Yehia L, Eng C. PTEN Hamartoma Tumor Syndrome. 2001 Nov 29 [Updated 2025 Aug 7; cited 2025 Sep 25]. In: Adam MP, Everman DB, Mirzaa GM, et al., editors. GeneReviews(r) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1488/

The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.